Log In
Print
BCIQ
Print
Print this Print this
 

TH-1 (Thorium-227)

Also known as: TH-1 Receptor Targeted Delivery

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionThorium-227 linked to the mAb rituximab using targeted thorium conjugates (TTC) platform
Molecular Target
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat various cancers
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today